Skip to main content
. 2019 Sep 4;18(5):4467–4480. doi: 10.3892/ol.2019.10807

Figure 5.

Figure 5.

Kaplan-Meier survival curves of OS and PRFS based on ex-miR-21 expression in patients with stage III GC. (A) Comparison of OS between patients with stage III GC with high and low expression levels of ex-miR-21 (n=80). (B) Comparison of PRFS between patients with stage III GC with high and low expression levels of ex-miR-21 (n=80). ex-miR-21, exosome-encapsulated microRNA-21; GC, gastric cancer; OS, overall survival; PRFS, peritoneal recurrence-free survival.